As a globally trusted Anti Cancer (Oncology) product manufacturer in India, Taj Pharma Oncology stands at the forefront of innovation, quality, and affordability. With decades of industry-leading expertise, we have established ourselves as a premier manufacturer of a comprehensive range of oncology formulations, including liquid injections, lyophilized injections, oncology tablets, and oncology capsules. Our ultra-modern WHO-GMP compliant manufacturing facility at Daman, India, reflects our unwavering commitment to excellence and global healthcare standards.

We combine advanced technology with a patient-centric approach, ensuring that we deliver world-class cancer medicines at affordable prices to healthcare systems worldwide. As a specialty oncology manufacturer, we continuously strive to support oncologists, hospitals, and global distributors with high-quality formulations that meet stringent regulatory requirements.

---

Our Commitment to Quality Oncology Manufacturing

At Taj Pharma Oncology, we firmly follow the principles of Good Manufacturing Practices (GMP) and stringent quality assurance systems. Our facility is equipped with cutting-edge equipment for aseptic processing, sterile manufacturing, lyophilization, and formulation of highly potent oncology APIs.

We believe that access to quality cancer medicines is a right, not a privilege. Therefore, our mission is to deliver safe, effective, and affordable cancer therapies across global markets including Asia, Africa, CIS, Middle East, Latin America, and Europe.

We also contributed to global health preparedness during the COVID-19 pandemic with export-only productions of:

• Remdesivir for Injection (100 mg & 150 mg)
• Molnupiravir Capsules (200 mg, 400 mg, 800 mg)
• COMBIPACK of Nirmatrelvir 150 mg + Ritonavir 100 mg

---

Comprehensive Oncology Product Portfolio

Our oncology division covers a wide therapeutic spectrum across multiple cancer types, offering reliable, effective, and globally compliant formulations.

---

Oncology Capsules Manufacturer in India

Product Name	Available Strengths	Dosage Form	Therapeutic Category	BCS Class (Est.)
Aprepitant	125 mg/80 mg (Kit)	Capsule	Antiemetic (NK1 Antagonist)	Class II
Enzalutamide	40 mg	Capsule	Prostate Cancer (Androgen Receptor Inhibitor)	Class II
Hydroxyurea	500 mg	Capsule	Antineoplastic	Class I
Lenalidomide	5 mg, 10 mg, 15 mg, 20 mg, 25 mg	Capsule	Immunomodulator	Class IV
Lenvatinib	4 mg, 10 mg	Capsule	Tyrosine Kinase Inhibitor	Class II
Nilotinib	150 mg, 200 mg	Capsule	BCR-ABL Inhibitor	Class II
Sunitinib	12.5 mg, 25 mg, 37.5 mg, 50 mg	Capsule	Tyrosine Kinase Inhibitor	Class II
Pomalidomide	1 mg, 2 mg, 3 mg, 4 mg	Capsule	Immunomodulator	Class IV

---

TABLETS

Product Name	Available Strengths	Dosage Form	Therapeutic Category	BCS Class (Est.)
Anastrozole	1 mg	Tablet	Breast Cancer (Aromatase Inhibitor)	Class II
Abiraterone	250 mg, 500 mg	Tablet	Prostate Cancer	Class IV
Azathioprine	50 mg	Tablet	Immunosuppressant	Class II
Bicalutamide	50 mg	Tablet	Prostate Cancer	Class II
Chlorambucil	2 mg	Tablet	Antineoplastic	Class I
Cyclophosphamide	50 mg	Tablet	Alkylating Agent	Class I
Dasatinib	20 mg, 50 mg, 70 mg, 80 mg, 100 mg, 140 mg	Tablet	BCR-ABL TKI	Class II
Erlotinib	25 mg, 100 mg, 150 mg	Tablet	EGFR Inhibitor	Class II
Everolimus	5 mg, 10 mg	Tablet	mTOR Inhibitor	Class II
Exemestane	25 mg	Tablet	Aromatase Inhibitor	Class II
Flutamide	250 mg	Tablet	Antiandrogen	Class II
Gefitinib	250 mg	Tablet	EGFR Inhibitor	Class II
Imatinib	100 mg, 400 mg	Tablet	BCR-ABL TKI	Class II
Lapatinib	250 mg	Tablet	HER2/EGFR TKI	Class II
Letrozole	2.5 mg	Tablet	Aromatase Inhibitor	Class II
Melphalan	2 mg	Tablet	Alkylating Agent	Class I
Mercaptopurine	50 mg	Tablet	Antineoplastic	Class I
Methotrexate	2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 25 mg	Tablet	Antimetabolite	Class III
Pazopanib	200 mg, 400 mg	Tablet	VEGFR TKI	Class II
Sorafenib	200 mg	Tablet	Multikinase Inhibitor	Class II

---

LIQUID INJECTIONS

Product Name	Available Strengths	Dosage Form	Therapeutic Category	BCS Class (Est.)
Carboplatin	50 mg/5 ml, 150 mg/15 ml, 450 mg/45 ml	Injection	Platinum-Based Chemotherapy	Not Applicable
Cisplatin	50 mg/50 ml, 10 mg/10 ml	Injection	Platinum-Based Chemotherapy	Not Applicable
Cytarabine	100 mg/ml, 500 mg/5 ml, 1000 mg/10 ml	Injection	Antimetabolite	Not Applicable
Docetaxel	20 mg/0.5 ml, 80 mg/2 ml	Injection (Conc.)	Taxane Chemotherapy	Not Applicable
Fluorouracil (5-FU)	250 mg/5 ml	Injection	Antimetabolite	Not Applicable
Fulvestrant	250 mg/5 ml (PFS)	Injection	Estrogen Receptor Downregulator	Not Applicable
Irinotecan HCl	40 mg/2 ml, 100 mg/5 ml	Injection	Topoisomerase I Inhibitor	Not Applicable
Leucovorin Calcium	30 mg/3 ml, 50 mg/5 ml, 100 mg/10 ml	Injection	Chemoprotective Agent	Not Applicable
Mesna	200 mg/2 ml, 400 mg/4 ml	Injection	Uroprotectant	Not Applicable
Methotrexate	50 mg/2 ml, 500 mg/20 ml, 1000 mg/10 ml	Injection	Antimetabolite	Not Applicable
Oxaliplatin	50 mg/25 ml, 100 mg/50 ml	Injection	Platinum-Based Chemotherapy	Not Applicable
Paclitaxel	100 mg/16.7 ml, 150 mg/25 ml, 260 mg/43.4 ml, 300 mg/50 ml	Injection	Taxane Chemotherapy	Not Applicable
PEG L-Asparaginase	3750 IU/5 ml	Injection	Enzyme-Based Therapy	Not Applicable

---

LYOPHILIZED INJECTIONS

Product Name	Available Strengths	Dosage Form	Therapeutic Category	BCS Class (Est.)
Bleomycin	15 Units/Vial	Lyophilized Injection	Antineoplastic	Not Applicable
Bortezomib	3.5 mg/Vial	Lyophilized Injection	Proteasome Inhibitor	Not Applicable
Carfilzomib	60 mg/Vial	Lyophilized Injection	Proteasome Inhibitor	Not Applicable
Dacarbazine	200 mg/Vial	Lyophilized Injection	Alkylating Agent	Not Applicable
Daunorubicin	20 mg/Vial	Lyophilized Injection	Anthracycline	Not Applicable
Doxorubicin	10 mg/Vial, 50 mg/Vial	Lyophilized Injection	Anthracycline	Not Applicable
Epirubicin	10 mg/Vial, 50 mg/Vial	Lyophilized Injection	Anthracycline	Not Applicable
Gemcitabine	200 mg/Vial, 1000 mg/Vial	Lyophilized Injection	Antimetabolite	Not Applicable
Ifosfamide	1000 mg/Vial	Lyophilized Injection	Alkylating Agent	Not Applicable
L-Asparaginase	10000 IU/Vial	Lyophilized Injection	Enzyme-Based Therapy	Not Applicable
Mitomycin	20 mg/Vial	Lyophilized Injection	Antineoplastic Antibiotic	Not Applicable

---

UPCOMING PRODUCTS

Product Name	Available Strengths	Dosage Form	Therapeutic Category	BCS Class (Est.)
Olaparib	100 mg	Tablet	PARP Inhibitor	Class II
Palbociclib	75 mg, 100 mg, 125 mg	Tablet	CDK4/6 Inhibitor	Class II
Palbociclib	75 mg, 100 mg, 125 mg	Capsule	CDK4/6 Inhibitor	Class II
Relugolix	120 mg	Tablet	GnRH Receptor Antagonist	Class II

---

Upcoming Oncology Products

We continue to invest heavily in research, formulation development, and pipeline expansion with upcoming launches:

• Olaparib Tablets 100 mg
• Palbociclib Tablets – 75 mg, 100 mg, 125 mg
• Palbociclib Capsules – 75 mg, 100 mg, 125 mg
• Relugolix Tablets 120 mg

This pipeline reinforces our long-term vision to remain a leading oncology manufacturer in India.

---

Why Global Buyers Choose Taj Pharma Oncology

✔ WHO-GMP, GLP, PIC/S & ISO-certified oncology facilities

✔ Large-scale manufacturing capacity for global supply

✔ Cost-effective contract manufacturing and private labeling

✔ Strict compliance with international regulatory norms

✔ Dedicated oncology R&D and stability testing labs

✔ Global export experience in 42+ countries

From formulation to packaging, every step in our production ensures unmatched precision, sterility, and safety.

---

Global Exporter of Oncology Medicines

We cater to government tenders, oncology distributors, hospitals, cancer centers, NGOs, and multinational pharmaceutical buyers. Our products are exported to:

• Africa
• Southeast Asia
• Middle East
• CIS Region
• Latin America
• Europe (select markets)

Our established cold-chain logistics ensure that oncology medicines reach international destinations in perfect condition.

---

Taj Pharma Oncology remains fully committed to enabling access to high-quality, affordable anti-cancer medicines across global healthcare ecosystems. With an extensive oncology product portfolio, robust manufacturing capabilities, and a relentless focus on patient safety, we continue to establish ourselves as the most trusted oncology product manufacturer in India.

We strive to support oncologists, empower distributors, and strengthen worldwide cancer care through innovation, integrity, and uncompromised quality.